7,8-CYCLICMORPHINAN-ANALOGE

Patent europeic · EP2941430 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2941430
Numer da la dumonda
EP13823991
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
23-12-2013
Publitgà
11-11-2015
Concedì
26-04-2017
Stritgà
31-12-2017
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 215/14 (2006.01)
C07D 471/08 (2006.01)
Prioritad
US 201261746934 P 28.12.2012
Dumonda PCT
PCT/IB2013/002869 23.12.2013
Publicaziun PCT
WO2014/102587 03.07.2014
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 18-07-2018

    Stritgà, taxa betg pajada

    Published in Swissreg on 18.07.2018

  2. 26-04-2017

    Concedì

    Published in Swissreg on 26.04.2017

Partidas

Possessur

Purdue Pharma LP

One Stamford Forum 201 Tresser Boulevard, Stamford, CT 06901-3431, US

Inventur

KYLE, Donald, James

Yardley, PA 19067, US

TAFESSE, Laykea

Robbinsville, NJ 08690, US

ZHOU, Xiaoming

Plainsboro, NJ 08536, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.